Cooper Companies | COO - 資産





資産 変化する 日付
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Avanos Medical USD 1.05B 23.6M 2026-03
Bausch Health Companies USD 24.5B 1.87B 2026-03
Baxter International USD 19.85B 209M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Cooper Companies USD 12.48B 58.1M 2026-03
Dentsply International USD 5.23B 200M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
Haemonetics USD 2.4B 94.96M 2026-03
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Novartis USD 110.95B 3.66B 2025-12
ResMed USD 8.78B 280.91M 2026-03
STAAR Surgical USD 451.12M 560K 2026-03
Steris USD 10.74B 145.8M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Utah Medical Products USD 122.54M 567K 2025-12
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03